Article Text
Statistics from Altmetric.com
Prader-Willi syndrome (PWS) is characterised by infantile hypotonia, feeding difficulties, hypogonadism, small hands and feet, mental deficiency, obesity in early childhood, a particular facial appearance, and a paternally derived 15q11-q13 deletion (approximately 4 million bp in size) in about 70% of subjects, maternal disomy 15 (both 15s from the mother) in 25% of subjects, or an imprinting mutation in 2-5% of subjects.1–4 PWS syndrome is considered to be the most common genetic cause of marked obesity in humans.1
Two breakpoint clusters have been reported centromeric to locus ZNF127 with the most proximal breakpoint (BP1) accounting for 44% of cytogenetic deletions while 56% of deletions occur at the second proximal breakpoint (BP2).5, 6 The second breakpoint (BP2) lies between loci D15S541/S542 and D15S543 and breakpoint BP1 is proximal to D15S541/S542.5, 6 A third breakpoint (BP3) is distally located within the 15q11-q13 region and mapped telomeric to the P locus (involved in hypopigmentation) in nearly all deletion subjects studied.5–13 The apparent genetic instability in the 15q11-q13 region may be attributed to DNA sequences identified in low copy repeats in the vicinity of the common breakpoints occurring in patients with PWS. These END repeats are derived from large genomic duplications of a novel gene (HERC2).8, 12 The END repeats flanking the 15q11-q13 region may be involved with inter- and intrachromosomal misalignment and homologous recombination resulting in the common PWS deletion and facilitated by active transcription of the END repeats in male and female …